Document Detail


Rituximab in a patient with ankylosing spondylitis with demyelinating disease: a case report and review of the literature.
MedLine Citation:
PMID:  22644089     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Tumor necrosis factor inhibitors (TNFI) are novel therapies used to treat ankylosing spondylitis (AS). Demyelinating disease is a rare but serious complication of TNFI. We report a patient with a case of AS who developed demyelinating disease secondary to TNFI and was treated successfully with rituximab.
Authors:
Mohammed A Omair; Khalid A Alnaqbi; Peter Lee
Related Documents :
22454809 - Methamphetamine-induced paralytic ileus.
536159 - Intralesional steroids in conservative management of subglottic stenosis of the larynx.
22843749 - A rare but severe pulmonary side effect of cetuximab in two patients.
20454809 - Post-intubation long-segment tracheal stenosis of the posterior wall: a case report and...
20229469 - A report of csf leak as a complication of nasal packing for epistaxis.
22556329 - Bordetella holmesii meningitis in an asplenic patient with systemic lupus erythematosus.
1248349 - Anal fistula: a review of 82 cases.
3599149 - Retrieval of intravascular foreign bodies.
18331639 - Migration of superior vena cava stent.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-27
Journal Detail:
Title:  Clinical rheumatology     Volume:  -     ISSN:  1434-9949     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Medicine, Division of Rheumatology, Mount Sinai Hospital, Toronto, ON, Canada, momair@mtsinai.on.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beware of the biologicals-hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1...
Next Document:  Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis.